About 5-methyl-3-[1-methyl-6-(trifluoromethyl)benzimidazol-2-yl]-2H-1,3,4-oxadiazole
5-methyl-3-[1-methyl-6-(trifluoromethyl)benzimidazol-2-yl]-2H-1,3,4-oxadiazole (PubChem CID 138692158) has the molecular formula C12H11F3N4O
and a molecular weight of 284.24 g/mol. Its IUPAC name is 5-methyl-3-[1-methyl-6-(trifluoromethyl)benzimidazol-2-yl]-2H-1,3,4-oxadiazole.
Analyze 5-methyl-3-[1-methyl-6-(trifluoromethyl)benzimidazol-2-yl]-2H-1,3,4-oxadiazole with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of 5-methyl-3-[1-methyl-6-(trifluoromethyl)benzimidazol-2-yl]-2H-1,3,4-oxadiazole?
The IUPAC name of 5-methyl-3-[1-methyl-6-(trifluoromethyl)benzimidazol-2-yl]-2H-1,3,4-oxadiazole (CID 138692158) is 5-methyl-3-[1-methyl-6-(trifluoromethyl)benzimidazol-2-yl]-2H-1,3,4-oxadiazole.
What is the SMILES notation for 5-methyl-3-[1-methyl-6-(trifluoromethyl)benzimidazol-2-yl]-2H-1,3,4-oxadiazole?
The canonical SMILES for 5-methyl-3-[1-methyl-6-(trifluoromethyl)benzimidazol-2-yl]-2H-1,3,4-oxadiazole is CC1=NN(c2nc3ccc(C(F)(F)F)cc3n2C)CO1.
What is the InChIKey of 5-methyl-3-[1-methyl-6-(trifluoromethyl)benzimidazol-2-yl]-2H-1,3,4-oxadiazole?
The InChIKey is RLCUGJIXERRAAX-UHFFFAOYSA-N. The full InChI is InChI=1S/C12H11F3N4O/c1-7-17-19(6-20-7)11-16-9-4-3-8(12(13,14)15)5-10(9)18(11)2/h3-5H,6H2,1-2H3.
What are the key properties of 5-methyl-3-[1-methyl-6-(trifluoromethyl)benzimidazol-2-yl]-2H-1,3,4-oxadiazole?
5-methyl-3-[1-methyl-6-(trifluoromethyl)benzimidazol-2-yl]-2H-1,3,4-oxadiazole has a molecular weight of 284.24 g/mol, XLogP of 2.72, 1 rotatable bonds, 0 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for 5-methyl-3-[1-methyl-6-(trifluoromethyl)benzimidazol-2-yl]-2H-1,3,4-oxadiazole is sourced from PubChem (CID 138692158), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).